NOTCH1 drives immune-escape mechanisms in B cell malignancies
Mangolini, M.; Maiques-Diaz, A.; Charalampopoulou, S.; Gerhard-Hartmann, E.; Bloehdorn, J.; Moore, A.; Lu, J.; Roamio Franklin, V. N.; Chilamakuri, C. S.; Moutsoupoulos, I.; Rosenwald, A.; Stilgenbauer, S.; Zenz, T.; Mohorianu, I.; DSantos, C.; Deaglio, S.; Martin-Subero, J. I.; Ringshausen, I.
Show abstract
NOTCH1 is a recurrently mutated gene in Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL). Functional studies to investigate its role have been hampered by the inability to genetically manipulate primary human lymphoma cells, attributed to low transduction-efficacy and procedure-associated toxicity. To overcome these limitations, we have developed a novel method to retrovirally transfer genes into malignant human B cells. We generated isogenic human tumor cells from patients with CLL and MCL, differing only in their expression of NOTCH1. Our data demonstrate that NOTCH1 facilitates immune-escape of malignant B cells by up-regulating PD-L1, partly dependent on autocrine interferon-{gamma} signaling. In addition, NOTCH1 causes silencing of the entire HLA-class II locus via suppression of the transcriptional co-activator CIITA. These NOTCH1-mediated immune escape mechanisms are associated with the expansion of CD4+ T cells in vivo, further contributing to the poor clinical outcome of NOTCH1-mutated CLL and MCL.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Network analysis reveals a major role for 14q32 cluster miRNAs in determining transcriptional differences between IGHV-mutated and unmutated CLL 97%
- EOMES and IL-10 regulate anti-tumor activity of PD-1+ CD4+ T-cells in B-cell Non-Hodgkin lymphoma 95%
- Low-affinity CAR T cells exhibit reduced trogocytosis, preventing fratricide and antigen-negative tumor escape while preserving anti-tumor activity 95%
Similar papers in this journal
- Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of Diffuse Large B Cell Lymphoma 96%
- MondoA Drives Malignancy in cALL through Enhanced Adaptation to Metabolic Stress 94%
- Alternative splicing of its 5'-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies 94%
Similar papers in this journal
- ATP citrate lyase is an essential player of the metabolic rewiring induced by PTEN loss during T-ALL development. 95%
- Single-cell profiling identifies clinically relevant interactions between tumor associated macrophages and blood endothelial cells in diffuse large B cell lymphoma 95%
- Resistance mechanism to Notch inhibition and combination therapy in human T cell acute lymphoblastic leukemia 94%
Similar papers in this journal
- Proliferating CLL cells express high levels of CXCR4 and CD5 97%
- In vitro lymph node-mimicking 3D model displays long-term T cell-dependent CLL proliferation and survival 95%
- NOTCH1 fusions in pediatric T-cell lymphoblastic lymphoma: a high-risk subgroup with CCL17 (TARC) levels as diagnostic biomarker 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.